Condition
Respiratory Illness
Total Trials
7
Recruiting
0
Active
0
Completed
6
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
29%
2 trials in Phase 3/4
Results Transparency
17%
1 of 6 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
7Total
Not Applicable (5)
P 3 (2)
Trial Status
Completed6
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT04327206Phase 3Completed
BCG Vaccination to Protect Healthcare Workers Against COVID-19
NCT04471766Not ApplicableUnknown
Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention
NCT00421668Phase 3Completed
A Trial of Zinc and Micronutrients in Tanzanian Children
NCT00499915Not ApplicableCompletedPrimary
NICU Asthma Education and Secondhand Smoke Reduction Study
NCT01043809Not ApplicableCompleted
Evaluation of a Handwashing Promotion Program in Three Countries
NCT00995254Not ApplicableCompleted
Secondhand Smoke Exposure Reduction Among Young Children in China
NCT00437541Not ApplicableCompletedPrimary
Housing, Insulation and Health Study
Showing all 7 trials